Top compounds associated with response to LGALS9C


Feature Type Standardized
Nominal ANOVA
mRNA SR-II-138A CTRPv2 pan-cancer AAC 0.02 0.5
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.022 0.5
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.024 0.5
mRNA SZ4TA2 CTRPv2 pan-cancer AAC -0.034 0.5
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.022 0.5
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.5
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA Crizotinib gCSI pan-cancer AAC -0.035 0.5
mRNA Bortezomib gCSI pan-cancer AAC -0.037 0.5
mRNA fulvestrant CTRPv2 pan-cancer AAC -0.054 0.5
Download CSV